08:34 AM EDT, 08/19/2024 (MT Newswires) -- Accenture ( ACN ) said Monday that it has invested in biotechnology firm Earli through its Accenture Ventures unit.

Financial terms of the investment were not disclosed.

Earli created an approach to trace early cancer with a synthetic targeting platform. The investment will support partnerships with health and pharmaceutical companies that can use Earli's cancer detection and treatment technology, Accenture ( ACN ) said.

Earli will join Accenture Ventures' Project Spotlight, an investment program with companies that develop or apply enterprise technologies, Accenture ( ACN ) said.

Price: 324.00, Change: -2.92, Percent Change: -0.89